urinary stones
Conditions
Interventions
Blank control group 2:Prevention of stone recurrence without oral administration of total flavonoid capsules of Strychnos militaris
a debris removal group:Oral administration of total flavonoid capsules of Strychnos militaris 3 capsules/dose 3 times/day
Blank control group 1:Not taking oral strychnine capsules for stone removal
prophylactic group:Oral administration of total flavonoid capsule of Strychnos militaris 2 capsules/dose 2 times/day
Sponsors
Guangdong Hospital of Traditional Chinese Medicine Fangcun Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Those who meet the western medical diagnostic criteria of upper urinary tract stones; 2) Those whose Chinese medicine diagnosis is consistent with the evidence of damp-heat accumulation; 3)Age between 18 and 70 years old; 4) After minimally invasive surgery for stones patients who are suitable for and receive Total Flavonoid Capsule of Stonecrop suitable for lithotripsy 0.4cm > stone diameter ¡À0.8cm suitable for prevention of stone recurrence for all patients with urinary stones; 5) Imaging results show good renal function especially good renal function on the affected side and if the patient has hydronephrosis the degree of hydronephrosis is moderate and below; 6) General condition of the whole body is good and the patient can take care of himself/herself; 7)Voluntarily sign the informed consent form and be able to complete the study according to the requirements of the trial protocol.
Exclusion criteria
Exclusion criteria: 1) Target stones are bladder stones and urethral stones; 2) imaging results show that the kidney ureteral junction or the distal ureter of the stone has deformity stenosis obstruction and surgical scar adhesion; 3) Monitor the laboratory test indexes during the medication period if there is liver and kidney function impairment then out of the group; 4) Those with persistent severe hematuria even shock; 5) Those with acute obstructive oliguria anuria renal failure chronic uremia medullary sponge kidney severe urinary tract infection; 6)Women in pregnancy or preparing for pregnancy or breastfeeding; women with positive urine pregnancy test; 7)Those with a combination of serious primary diseases of the cardiovascular cerebrovascular hepatic renal and hematopoietic systems; or serious organic diseases of other organs; or serious diseases known to affect the patient's survival (e.g. neoplasms or AIDS); or patients with mental or legal disabilities; 8) Other pathologies that in the judgment of the investigator have the effect of reducing the likelihood of enrollment or complicating enrollment such as frequent changes in the work environment that could easily result in loss of visits; 9) Known hypersensitivity to the drug or its constituent parts.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stone recurrence rate during the follow-up period after the end of the intervention period;Residual stone expulsion rate during the treatment cycle;Residual stone excretion rate during the prevention cycle; | — |
Secondary
| Measure | Time frame |
|---|---|
| USSQ scores;Chinese Medicine Score; | — |
Countries
China
Contacts
Public ContactSongtao Xiang
Guangdong Hospital of Traditional Chinese Medicine
Outcome results
None listed